Serum biomarkers associated with SARS-CoV-2 severity
| Autor(a) principal: | |
|---|---|
| Data de Publicação: | 2022 |
| Outros Autores: | , , , , , , , , , , , , , , , , , , , , , , , |
| Tipo de documento: | Artigo |
| Idioma: | eng |
| Título da fonte: | Repositório Institucional da FIOCRUZ (ARCA) |
| Texto Completo: | https://www.arca.fiocruz.br/handle/icict/55665 |
Resumo: | Federal University of Mato Grosso do Sul. School of Medicine. Campo Grande, MS, Brazil. |
| id |
CRUZ_611490a2624f8cfce82eff5aff48a9da |
|---|---|
| oai_identifier_str |
oai:www.arca.fiocruz.br:icict/55665 |
| network_acronym_str |
CRUZ |
| network_name_str |
Repositório Institucional da FIOCRUZ (ARCA) |
| repository_id_str |
2135 |
| spelling |
Batista, Fabiani de MoraisPuga, Marco Antonio MoreiraSilva, Patricia Vieira daOliveira, RobertoSantos, Paulo Cesar Pereira dosSilva, Bruna Oliveira daTatara, Mariana BentoTsuha, Daniel HenriquePires, Maria Aparecida dos SantosGonçalves, Crhistinne Cavalheiro MaymoneSilva, Rômulo Pessoa E.Ferreira, Nathália TavaresAlbuquerque, Amanda Pinheiro de BarrosDuarte, Giselle da SilvaConsolaro, Márcia Edilaine LopesNegrão, Fabio JulianoFerrari, Idalina CristinaCavalcanti, Luciano Pamplona de GoesTrinta, Karen SoaresRibeiro, Guilherme S.Rêgo, Moacyr Jesus Barreto de MeloBoyton, Rosemary J.Siqueira, André MachadoAltmann, Daniel M.Croda, Julio2022-11-16T19:40:48Z2022-11-16T19:40:48Z2022BATISTA, Fabiani de Morais et al. Serum biomarkers associated with SARS-CoV-2 severity. Scientific Reports, v. 12, n. 1, p. 1-9, 2022.2045-2322https://www.arca.fiocruz.br/handle/icict/5566510.1038/s41598-022-20062-5engNatureSerum biomarkers associated with SARS-CoV-2 severityinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleFederal University of Mato Grosso do Sul. School of Medicine. Campo Grande, MS, Brazil.Federal University of Mato Grosso do Sul. School of Medicine. Campo Grande, MS, Brazil.Federal University of Mato Grosso do Sul. School of Medicine. Campo Grande, MS, Brazil.State University of Mato Grosso do Sul. Associated Prof. Nursing Course. Dourados, MS, Brazil.Federal University of Mato Grosso do Sul. School of Medicine. Campo Grande, MS, Brazil.Federal University of Grande Dourados. Faculty of Health Science. Laboratory of Research in Health Science. Dourados, MS, Brazil.Federal University of Grande Dourados. Faculty of Health Science. Laboratory of Research in Health Science. Dourados, MS, Brazil.Center for Strategic Information in Health Surveillance. State Health Department of Mato Grosso do Sul. Campo Grande, MS, Brazil.Federal University of Grande Dourados. Faculty of Health Sciences. Dourados, MS, Brazil / Federal University of Grande Dourados. Universitary Hospital. Dourados, MS, Brazil.Federal University of Mato Grosso do Sul. School of Medicine. Campo Grande, MS, Brazil.Federal University of Pernambuco. Recife, PE, Brazil.Federal University of Pernambuco. Recife, PE, Brazil.Federal University of Pernambuco. Recife, PE, Brazil.Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Laboratório de Pesquisa Clínica de Doença Febril Aguda. Rio de Janeiro, RJ, Brasil.State University of Maringá. Postgraduate Program in Biosciences and Pathophysiology. Maringá, PR, Brazil / State University of Maringá. Regional University Hospital of Maringá. Maringá, PR, Brazil.Federal University of Grande Dourados. Faculty of Health Sciences. Dourados, MS, Brazil / Federal University of Grande Dourados. Universitary Hospital. Dourados, MS, Brazil.Federal University of Grande Dourados. Faculty of Health Sciences. Dourados, MS, Brazil.Federal University of Ceará. Postgraduate Program in Public Health. Fortaleza, CE, Brazil / Christus University Center. School of Medicine. Fortaleza, CE, Brazil / Federal University of Ceará. Postgraduate Program in Pathology. Fortaleza, CE, Brazil .Fundação Oswaldo Cruz. Bio-manguinhos. Laboratório de Tecnologia Diagnóstica. Rio de Janeiro, RJ, Brasil.Fundação Oswaldo Cruz. Instituto Gonçalo Moniz. Salvador, BA, Brasil / Universidade Federal da Bahia. Faculdade de Medicina. Salvador, BA, Brasil.Federal University of Pernambuco. Recife, PE, Brazil.Imperial College London. Department of Infectious Disease. London, UK / Royal Brompton. Lung Division. London, UK / Harefield Hospitals. London, UK.Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Rio de Janeiro, RJ, Brasil.Imperial College London. Department of Immunology and Inflammation. London, UK.Fundação Oswaldo Cruz. Fiocruz Mato Grosso do Sul. Campo Grande, MS, Brasil / Federal University of Mato Grosso do Sul. School of Medicine. Campo Grande, MS, Brazil.Immunity with SARS-CoV-2 infection during the acute phase is not sufficiently well understood to differentiate mild from severe cases and identify prognostic markers. We evaluated the immune response profile using a total of 71 biomarkers in sera from patients with SARS-CoV-2 infection, confirmed by RT-PCR and controls. We correlated biological marker levels with negative control (C) asymptomatic (A), nonhospitalized (mild cases-M), and hospitalized (severe cases-S) groups. Among angiogenesis markers, we identified biomarkers that were more frequently elevated in severe cases when compared to the other groups (C, A, and M). Among cardiovascular diseases, there were biomarkers with differences between the groups, with D-dimer, GDF-15, and sICAM-1 higher in the S group. The levels of the biomarkers Myoglobin and P-Selectin were lower among patients in group M compared to those in groups S and A. Important differences in cytokines and chemokines according to the clinical course were identified. Severe cases presented altered levels when compared to group C. This study helps to characterize biological markers related to angiogenesis, growth factors, heart disease, and cytokine/chemokine production in individuals infected with SARS-CoV-2, offering prognostic signatures and a basis for understanding the biological factors in disease severity.COVID-19SARS-CoV-2 severityRT-PCRSerum biomarkersinfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da FIOCRUZ (ARCA)instname:Fundação Oswaldo Cruz (FIOCRUZ)instacron:FIOCRUZLICENSElicense.txtlicense.txttext/plain; charset=utf-82991https://www.arca.fiocruz.br/bitstream/icict/55665/1/license.txt5a560609d32a3863062d77ff32785d58MD51ORIGINALSerum_Andre_Siqueira_etal_INI_2022.pdfSerum_Andre_Siqueira_etal_INI_2022.pdfapplication/pdf2324837https://www.arca.fiocruz.br/bitstream/icict/55665/2/Serum_Andre_Siqueira_etal_INI_2022.pdf057f993e708bb67d15e6b8116f7863b4MD52icict/556652023-02-26 00:23:03.625oai:www.arca.fiocruz.br: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ório InstitucionalPUBhttps://www.arca.fiocruz.br/oai/requestrepositorio.arca@fiocruz.bropendoar:21352023-02-26T03:23:03Repositório Institucional da FIOCRUZ (ARCA) - Fundação Oswaldo Cruz (FIOCRUZ)false |
| dc.title.en_US.fl_str_mv |
Serum biomarkers associated with SARS-CoV-2 severity |
| title |
Serum biomarkers associated with SARS-CoV-2 severity |
| spellingShingle |
Serum biomarkers associated with SARS-CoV-2 severity Batista, Fabiani de Morais COVID-19 SARS-CoV-2 severity RT-PCR Serum biomarkers |
| title_short |
Serum biomarkers associated with SARS-CoV-2 severity |
| title_full |
Serum biomarkers associated with SARS-CoV-2 severity |
| title_fullStr |
Serum biomarkers associated with SARS-CoV-2 severity |
| title_full_unstemmed |
Serum biomarkers associated with SARS-CoV-2 severity |
| title_sort |
Serum biomarkers associated with SARS-CoV-2 severity |
| author |
Batista, Fabiani de Morais |
| author_facet |
Batista, Fabiani de Morais Puga, Marco Antonio Moreira Silva, Patricia Vieira da Oliveira, Roberto Santos, Paulo Cesar Pereira dos Silva, Bruna Oliveira da Tatara, Mariana Bento Tsuha, Daniel Henrique Pires, Maria Aparecida dos Santos Gonçalves, Crhistinne Cavalheiro Maymone Silva, Rômulo Pessoa E. Ferreira, Nathália Tavares Albuquerque, Amanda Pinheiro de Barros Duarte, Giselle da Silva Consolaro, Márcia Edilaine Lopes Negrão, Fabio Juliano Ferrari, Idalina Cristina Cavalcanti, Luciano Pamplona de Goes Trinta, Karen Soares Ribeiro, Guilherme S. Rêgo, Moacyr Jesus Barreto de Melo Boyton, Rosemary J. Siqueira, André Machado Altmann, Daniel M. Croda, Julio |
| author_role |
author |
| author2 |
Puga, Marco Antonio Moreira Silva, Patricia Vieira da Oliveira, Roberto Santos, Paulo Cesar Pereira dos Silva, Bruna Oliveira da Tatara, Mariana Bento Tsuha, Daniel Henrique Pires, Maria Aparecida dos Santos Gonçalves, Crhistinne Cavalheiro Maymone Silva, Rômulo Pessoa E. Ferreira, Nathália Tavares Albuquerque, Amanda Pinheiro de Barros Duarte, Giselle da Silva Consolaro, Márcia Edilaine Lopes Negrão, Fabio Juliano Ferrari, Idalina Cristina Cavalcanti, Luciano Pamplona de Goes Trinta, Karen Soares Ribeiro, Guilherme S. Rêgo, Moacyr Jesus Barreto de Melo Boyton, Rosemary J. Siqueira, André Machado Altmann, Daniel M. Croda, Julio |
| author2_role |
author author author author author author author author author author author author author author author author author author author author author author author author |
| dc.contributor.author.fl_str_mv |
Batista, Fabiani de Morais Puga, Marco Antonio Moreira Silva, Patricia Vieira da Oliveira, Roberto Santos, Paulo Cesar Pereira dos Silva, Bruna Oliveira da Tatara, Mariana Bento Tsuha, Daniel Henrique Pires, Maria Aparecida dos Santos Gonçalves, Crhistinne Cavalheiro Maymone Silva, Rômulo Pessoa E. Ferreira, Nathália Tavares Albuquerque, Amanda Pinheiro de Barros Duarte, Giselle da Silva Consolaro, Márcia Edilaine Lopes Negrão, Fabio Juliano Ferrari, Idalina Cristina Cavalcanti, Luciano Pamplona de Goes Trinta, Karen Soares Ribeiro, Guilherme S. Rêgo, Moacyr Jesus Barreto de Melo Boyton, Rosemary J. Siqueira, André Machado Altmann, Daniel M. Croda, Julio |
| dc.subject.en.en_US.fl_str_mv |
COVID-19 SARS-CoV-2 severity RT-PCR Serum biomarkers |
| topic |
COVID-19 SARS-CoV-2 severity RT-PCR Serum biomarkers |
| description |
Federal University of Mato Grosso do Sul. School of Medicine. Campo Grande, MS, Brazil. |
| publishDate |
2022 |
| dc.date.accessioned.fl_str_mv |
2022-11-16T19:40:48Z |
| dc.date.available.fl_str_mv |
2022-11-16T19:40:48Z |
| dc.date.issued.fl_str_mv |
2022 |
| dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
| dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
| format |
article |
| status_str |
publishedVersion |
| dc.identifier.citation.fl_str_mv |
BATISTA, Fabiani de Morais et al. Serum biomarkers associated with SARS-CoV-2 severity. Scientific Reports, v. 12, n. 1, p. 1-9, 2022. |
| dc.identifier.uri.fl_str_mv |
https://www.arca.fiocruz.br/handle/icict/55665 |
| dc.identifier.issn.en_US.fl_str_mv |
2045-2322 |
| dc.identifier.doi.none.fl_str_mv |
10.1038/s41598-022-20062-5 |
| identifier_str_mv |
BATISTA, Fabiani de Morais et al. Serum biomarkers associated with SARS-CoV-2 severity. Scientific Reports, v. 12, n. 1, p. 1-9, 2022. 2045-2322 10.1038/s41598-022-20062-5 |
| url |
https://www.arca.fiocruz.br/handle/icict/55665 |
| dc.language.iso.fl_str_mv |
eng |
| language |
eng |
| dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
| eu_rights_str_mv |
openAccess |
| dc.publisher.none.fl_str_mv |
Nature |
| publisher.none.fl_str_mv |
Nature |
| dc.source.none.fl_str_mv |
reponame:Repositório Institucional da FIOCRUZ (ARCA) instname:Fundação Oswaldo Cruz (FIOCRUZ) instacron:FIOCRUZ |
| instname_str |
Fundação Oswaldo Cruz (FIOCRUZ) |
| instacron_str |
FIOCRUZ |
| institution |
FIOCRUZ |
| reponame_str |
Repositório Institucional da FIOCRUZ (ARCA) |
| collection |
Repositório Institucional da FIOCRUZ (ARCA) |
| bitstream.url.fl_str_mv |
https://www.arca.fiocruz.br/bitstream/icict/55665/1/license.txt https://www.arca.fiocruz.br/bitstream/icict/55665/2/Serum_Andre_Siqueira_etal_INI_2022.pdf |
| bitstream.checksum.fl_str_mv |
5a560609d32a3863062d77ff32785d58 057f993e708bb67d15e6b8116f7863b4 |
| bitstream.checksumAlgorithm.fl_str_mv |
MD5 MD5 |
| repository.name.fl_str_mv |
Repositório Institucional da FIOCRUZ (ARCA) - Fundação Oswaldo Cruz (FIOCRUZ) |
| repository.mail.fl_str_mv |
repositorio.arca@fiocruz.br |
| _version_ |
1813009033458614272 |